Contributors

Meet some of the people featured in the July 2012 issue of The Scientist.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Keith D. Wilkinson (far left) began studying the ubiquitin pathway in 1979 because it was “brand new.” He was recruited to Nobel Prize–winner Irwin Rose’s lab at the Fox Chase Cancer Center just a few short years after ubiquitin was first discovered. Today, Wilkinson is still figuring out the mysteries of a protein that is found in all eukaryotic cells and is fundamental to the cell cycle. He is currently identifying a host of enzymes that regulate ubiquitin-dependent processes, with the expectation that the enzymes will be good drug targets in disease. Wilkinson first met his coauthor David Fushman at a biannual ubiquitin meeting, where “everybody who is anybody in this field got their start.” Chains of ubiquitin are only distinguished by their pattern of connections, and Fushman wants to understand how the connections affect the signaling process. In their feature article, "On the Chain Gang," you can read about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery